Answer
Whether evinacumab enters human milk is unknown; human IgGs enter breast milk during the first few days after birth, then decrease to low concentrations, so infant risk cannot be excluded during that initial period, but afterwards evinacumab (Evkeeza) could be used during breastfeeding if clinically needed.
Sources for this answer
- Evkeeza 150 mg/ml concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked